Sign In
Buy NKTR
$72.76
+2.17 (+3.07%)
At Close: Aug 04, 2026
Canada Pension Plan Investment Board Takes $44,000 Position in Nektar Therapeutics (NASDAQ:NKTR)
07:20am, Friday, 19'th Jun 2020
Canada Pension Plan Investment Board acquired a new stake in Nektar Therapeutics (NASDAQ:NKTR) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and
Parametric Portfolio Associates LLC Reduces Stock Position in Nektar Therapeutics (NASDAQ:NKTR)
06:38am, Friday, 19'th Jun 2020
Parametric Portfolio Associates LLC trimmed its holdings in shares of Nektar Therapeutics (NASDAQ:NKTR) by 7.5% in the first quarter, according to its most recent filing with the Securities and Exchan
Innovations In Cancer Treatment That Could Render Chemotherapy Antiquated
10:27am, Thursday, 11'th Jun 2020
When thinking about the future of medicine, it often helps to look to the past. We believe that chemotherapy will one day be viewed as antiquated as lobotomies
Mizuho Securities Sticks to Their Buy Rating for Xeris Pharmaceuticals (XERS) - Markets
12:37pm, Sunday, 07'th Jun 2020
In a report issued on June 5, Difei Yang from Mizuho Securities maintained a Buy rating on Xeris Pharmaceuticals (XERS
Why Is Nektar (NKTR) Up 12% Since Last Earnings Report?
03:31pm, Saturday, 06'th Jun 2020
Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Los índices de Estados Unidos cierran al alza; el Dow Jones Industrial Average avanza un 3,15%
12:00am, Friday, 05'th Jun 2020
Los índices de Estados Unidos cierran al alza; el Dow Jones Industrial Average avanza un 3,15%
SAN FRANCISCO, June 4, 2020 /PRNewswire via COMTEX/ --
SAN FRANCISCO, June 4, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) today announced the...
Nektar Therapeutics Highlights Data From Phase 1b Study Of NKTR-358 At European Congress Of Rheumatology
09:02pm, Thursday, 04'th Jun 2020
Nektar Therapeutics (NASDAQ:NKTR) today announced the presentation of results from the Phase 1b study evaluating multiple ascending doses of NKTR-358, a first-in-class T regulatory cell stimulator, wh
Nektar Therapeutics (NASDAQ: NKTR) announced today that it will webcast an analyst and investor conference call on Friday, June 5, 2020 at 11:00 a.m. EDT during EULAR 2020. The event will follow Thurs
Blair William & Co. IL Sells 38,930 Shares of Nektar Therapeutics (NASDAQ:NKTR)
09:27am, Wednesday, 27'th May 2020
Blair William & Co. IL reduced its position in Nektar Therapeutics (NASDAQ:NKTR) by 13.6% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchang
7 Stocks Maverick Capital Continues to Buy
03:11pm, Tuesday, 26'th May 2020
Adobe and Avantor make the list Continue reading...
